Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Mindfulness meets exposure: a gentler path to treating OCD?

NCT ID NCT07484750

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new 10-week group therapy called Mindfulness-Based Exposure Therapy (MBET) for people with obsessive-compulsive disorder (OCD). The therapy combines mindfulness training with exposure exercises to help patients better manage distress and complete treatment. Researchers aim to see if this approach is more tolerable and effective than standard exposure therapy. The trial is recruiting 64 participants aged 16 to 55 with moderate to severe OCD.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
mindfulness-based exposure therapy (group behavioral intervention)
What this could lead to
If it works, this could offer a more tolerable treatment option for people with OCD who find standard exposure therapy too distressing.
What could go wrong
This is a small, early-stage trial with only 64 participants. The therapy may not prove more effective than existing treatments, and results may not apply to all OCD patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 64 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2026

Expected to finish

Jun 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

16 to 55 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Have a primary diagnosis of Obsessive-Compulsive Disorder (OCD) according to DSM-5 criteria * Are between 16 and 55 years of age (inclusive) * Have a Yale-Brown Obsessive Compulsive Scale (Y-BOCS) total score ≥ 16 * Have an education level of junior high school or above * Are medication-free or have been stabilized on psychotropic medication for at least 8 weeks * Have sufficient visual and auditory capabilities to complete study assessments * Are willing to participate and provide written informed consent Exclusion Criteria: * Meet DSM-5 criteria for any other psychiatric disorder besides OCD * Have severe OCD symptoms that prevent completion of assessments * Exhibit active suicidal ideation or high suicide risk * Have a serious somatic disease, central nervous system disease, or substance abuse history * Are pregnant, breastfeeding, or planning pregnancy * Have metal implants contraindicated for MRI (e.g., pacemakers, intracranial clips, metal dentures, arterial stents, joint fixations)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Obessive-compulsive disorder are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Shanghai mental health center

    RECRUITING

    Shanghai, Shanghai Municipality, 200030, China